Request for Proposals: U.S. - Japan Cooperative Medical Sciences Program Collaborative Awards, 2021
CRDF Global is accepting proposals from joint U.S., Japan, and other Regional Asia-Pacific (APac) based investigators working in the field of infectious disease and immunology research for the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards, 2021. This initiative is jointly conducted by CRDF Global utilizing funds provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the Japan Agency for Medical Research and Development (AMED). USJCMSP Collaborative Awards, 2021 represents the fifth round of a collaborative award program that was initiated in 2016, following the 50th anniversary celebration of the USJCMSP. The awards program aims to promote the inclusion of early-career and female scientists in collaborative research.
The purpose of the USJCMSP collaborative awards is to foster new or expanded infectious disease and immunology focused biomedical research collaborations between researchers in Japan, the APac region, and U.S. investigators and institutions. It is expected that proposals will focus on questions of direct relevance to the APac region that will add to global knowledge about infectious diseases and immunology. The USJCMSP continues to promote collaborations, especially to include early-stage and female scientists from around the region.
For more information visit:
Six to eight awards, each up to $60,000 USD, will be made in support of two-year projects. Collaborative research teams consisting of investigators from the U.S., Japan, and other APac countries are eligible to apply.
All submissions must be submitted via email to email@example.com no later than:
Tuesday, March 30, 2021 (23:59) Eastern Standard Time (EST), UTC-5
(i.e., Wednesday, March 31, 2021 (12:59) Japan Standard Time, UTC+9)
Japanese sub-teams are also required to complete e-Rad submission. For questions about the e-Rad, please contact AMED at firstname.lastname@example.org.
All other questions should be directed to email@example.com.